RecruitingNCT04366804
International Validation of Two Non-motor Scales in PD (NFS and SPARK)
International Validation of Two Non-motor Scales in Parkinson's Disease: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in Parkinson's Disease (SPARK) Scale
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
300 participants
Start Date
Dec 3, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).
Eligibility
Min Age: 30 YearsMax Age: 75 Years
Inclusion Criteria4
- Written informed consent;
- PD, according to the MDS criteria;
- Age of participants \> 30 and \< 75 years;
- Being fluent in the language in which the scales are applied.
Exclusion Criteria1
- \. Presence of PD dementia (defined as MoCA score \< 24).
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04366804
Related Trials
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
NCT0207113484 locations
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
NCT072169765 locations
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
NCT073860151 location
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT0717431066 locations
Imaging Depression in Parkinson's Disease
NCT064029551 location